Cleveland BioLabs

company

About

Cleveland BioLabs is a clinical-stage biotech developing a robust pipeline of drugs for multiple medical and defense applications.

  • 51 - 100

Details

Last Funding Type
Post-IPO Debt
Last Funding Money Raised
$10M
Industries
Biotechnology,Health Care,Medical
Founded date
Jan 1, 2003
Number Of Employee
51 - 100
Operating Status
Active

Cleveland BioLabs is a clinical-stage biotech developing a robust pipeline of drugs for multiple medical and defense applications, with a focus on oncology and tissue protection. The company pursues the research, development, and commercialization of proprietary products that have the potential to treat cancer, prevent, and treat acute radiation syndrome and counteract the toxic effects of radio and chemotherapies for oncology patients.

Cleveland BioLabs was established in 2003 and is headquartered in Buffalo, New York.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$10M
Cleveland BioLabs has raised a total of $10M in funding over 2 rounds. Their latest funding was raised on Oct 1, 2013 from a Post-IPO Debt round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Oct 1, 2013 Post-IPO Debt $10M 1 Hercules Capital Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Cleveland BioLabs is funded by 1 investors. Hercules Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Hercules Capital Yes Post-IPO Debt